Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
37%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
PINK
63
HOLDINGS
35%
ALSO IN HRTS
HRTS
43
HOLDINGS
40%
ALSO IN PINK
SECTOR DRIFT (PINK minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PINK |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.5% | 10.4% | 8.5% |
|
GILEAD SCIENCES INC | 4.9% | 3.3% | 3.3% |
|
JOHNSON & JOHNSON | 5.3% | 3.2% | 3.2% |
|
UNITEDHEALTH GROUP INC | 3.2% | 4.4% | 3.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% | 3.5% | 3.1% |
PINK Overweight Relative to HRTS
|
ARCUTIS BIOTHERAPEUTICS INC | 8.9% |
|
RESMED INC | 5.8% |
|
PURECYCLE TECHNOLOGIES INC | 4.7% |
|
PACIRA PHARMACEUTICALS INC | 3.5% |
|
REGENERON PHARMACEUTICALS | 3.4% |
|
CARDINAL HEALTH INC | 3.0% |
|
CIGNA CORPORATION | 2.6% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
ABBVIE INC | 2.2% |
|
DANAHER CORP | 2.2% |
PINK Underweight Relative to HRTS
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.7% |
 |
ASTRAZENECA PLC | -4.2% |
|
BOSTON SCIENTIFIC CORP | -3.0% |
 |
MEDTRONIC PLC | -3.0% |
|
NOVARTIS AG | -2.9% |
 |
NOVO NORDISK A/S-B | -2.5% |
|
MERCK & CO. INC. | -2.5% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -2.5% |
|
VERTEX PHARMACEUTICALS INC | -2.4% |
|
BRIDGEBIO PHARMA, INC. | -2.2% |